ReviewCureus2024

Efficacy of Rituximab Versus Cyclophosphamide and Mycophenolate for the Treatment of Interstitial Lung Disease in Systemic Sclerosis: A Systematic Review.

Aneri Parikh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.